表紙
市場調査レポート

米国の陽子線治療市場の見通し

US Proton Therapy Market Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 282154
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
米国の陽子線治療市場の見通し US Proton Therapy Market Outlook 2020
出版日: 2015年06月01日 ページ情報: 英文 75 Pages
概要

米国の陽子線治療市場は、2020年までに収益で約12億2,000万米ドルに達し、2014年〜2020年のCAGRで、11.4%の成長が見込まれています。

当レポートでは、米国の陽子線治療市場について調査分析し、市場の現状と見通し、主要動向、促進要因と抑制要因、競合情勢と戦略的分析など、体系的な情報を提供しています。

第1章 アナリストの見解

第2章 調査手法

第3章 米国の癌の人口統計

  • 発症率:州別
  • 発症率:部位別

第4章 現在の放射線治療

  • 三次元原体照射法 (3D-CRT)
  • 画像誘導放射線治療 (IGRT)
  • 強度変調放射線治療 (IMRT)
  • 定位放射線治療 (STRT)
  • 中性子治療
  • 陽子線治療

第5章 標準的な陽子線治療センターの構成要素

  • 陽子加速器
  • ビーム輸送システム
  • ビームデリバリーシステム
  • ノズル
  • 治療計画システム
  • 画像ビューア
  • 患者整位システム
  • 人材

第6章 米国の陽子線治療市場の見通し

  • 現在の市場規模と将来成長
  • 潜在的な患者数:州別
  • 既存・将来参入企業の分析
  • 機会の評価

第7章 市場動向

  • 処置室の多いセンターの増加
  • 小型の陽子加速器が普及

第8章 産業の促進要因と抑制要因

  • 促進要因
  • 抑制要因

第9章 競合情勢と戦略的分析

  • IBA Group
  • 日立製作所
  • Mevion Medical Systems
  • Varian

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

In light of an alarmingly rising incidence of cancers and limited treatment options, physicians are being forced to look beyond conventional treatments. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to a low number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients.

According to the "US Proton Therapy Market Outlook 2020", report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will breach a Billion dollar mark to attain revenue of around US$ 1.22 Billion by 2020, growing at a CAGR of 11.4% during the forecast period (2014-2020). The report provides an insight into the cancer demographics of USA and the various possible causes for a high cancer incidence in the country. The document covers a historical trend (2008-2014) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.

Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country, etc., we have performed an opportunity assessment for the potential of proton therapy in the US. We have been able to draw the current and future demands for a number of proton therapy centers in the country. Not only this, the report enlists the top ten states with the maximum potential for a proton therapy center. The list provides an insight into the current and future scenarios of centers along with an estimation of the shortage of proton centers in each state which can help service providers and vendors to extract benefits from the largely untapped but lucrative market.

As for the market, the report provides a state-wide distribution of proton therapy centers in the US. A thorough analysis has been done on the existing and upcoming proton therapy centers to measure the market size and its future condition.

Following that, RNCOS was able to deduce various trends, drivers and challenges which would have a major influence in shaping the growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2020 for service providers and equipment vendors. There is also a 'strengths-weakness' analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in US till 2020, thus making it a must read for consultants and companies planning to enter the market.

Table of Contents

1. Analyst View

2. Research Methodology

3. US Cancer Demographics

  • 3.1 Incidence by State
  • 3.2 Incidence by Site

4. Current Radiation Therapies

  • 4.1 Third Dimensional Conformal Therapy (CRT)
  • 4.2 Image Guided Radiotherapy (IGRT)
  • 4.3 Intensity Modulated Radiotherapy (IMRT)
  • 4.4 Stereotactic Radiotherapy
  • 4.5 Neutron Therapy
  • 4.6 Proton Therapy
    • 4.6.1 Why Proton Therapy?

5. Components of a Standard Proton Therapy Center

  • 5.1 Proton Accelerator
  • 5.2 Beam Transport System
  • 5.3 Beam Delivery System
  • 5.4 Nozzle
    • 5.4.1 Single Scattering
    • 5.4.2 Double Scattering
    • 5.4.3 Uniform Scanning Nozzle
    • 5.4.4 Pencil Scanning Nozzle
  • 5.5 Treatment Planning System
  • 5.6 Image Viewers
  • 5.7 Patient Positioning System
  • 5.8 Human Resource

6. US Proton Therapy Market Outlook to 2018

  • 6.1 Current Market Size and Future Growth
  • 6.2 Potential Patients by State (2014 & 2020)
    • 6.2.1 Market Penetration
  • 6.3 Analysis of Existing and Forthcoming Players
    • 6.3.1 Service Providers
    • 6.3.2 Equipment Providers
  • 6.4 Opportunity Assessment

7. Market Trends

  • 7.1 Increasing Centers with More Number of Treatment Rooms
  • 7.2 Penetration of Smaller Proton Accelerators Increasing

8. Industry Drivers and Restraints

  • 8.1 Drivers
    • 8.1.1 Increasing Incidence of Cancer
    • 8.1.2 Benefits over Conventional Therapies
  • 8.2 Restraints
    • 8.2.1 Reimbursement Issues
    • 8.2.2 High Prices

9. Competitive Landscape and Strategic Analysis

  • 9.1 IBA Group
  • 9.2 Hitachi
  • 9.3 Mevion Medical Systems
  • 9.4 Varian

List of Figures:

  • Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
  • Figure 5-1: Components of a Proton Therapy Center
  • Figure 6-1: Proton Therapy Market (Million US$), 2014-2020
  • Figure 6-2: Share of Proton Therapy Market in Potential Market (2014)
  • Figure 6-3: Share of Proton Therapy Market in Potential Market (2020)
  • Figure 6-4: Market Share of Service Providers (2014)
  • Figure 6-5: Market Share of Service Providers (2020)
  • Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2014)
  • Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2020)
  • Figure 6-8: Demand of Proton Therapy Centers (2014 & 2020)
  • Figure 6-9: Shortage of Proton Therapy Centers (2014 & 2020)
  • Figure 7-1: Proton Therapy Center by Number of Treatment Rooms (2014 & 2020)
  • Figure 7-2: Proton Therapy Center by Type of Proton Accelerator (2014 & 2020)
  • Figure 8-1: Cancer Incidence (Million), 2008-2014
  • Figure 8-2: Cancer Mortality ('000), 2008-2014
  • Figure 9-1: IBA: Breakdown of Revenue by Activity (2014)

List of Tables:

  • Table 3-1: Cancer Incidence by State (Million), 2008-2014
  • Table 3-2: Cancer Incidence by Site (Million), 2008-2014
  • Table 6-1: State-wide Potential Patients for Proton Therapy (2014)
  • Table 6-2: State-wide Potential Patients for Proton Therapy (2020)
  • Table 6-3: Proton Therapy Centers (2014)
  • Table 6-4: Upcoming Proton Therapy Centers (2015 to 2019)
  • Table 6-5: Proton Therapy Equipment Providers with number of Installations till 2014
  • Table 6-6: Proton Therapy Equipment Providers with Number of Installations by 2020
  • Table 6-7: Shortage of Proton Therapy Centers (2020)
  • Table 9-1: IBA - Proton Therapy Products and Services
  • Table 9-2: IBA - Key Financials (Million Euro), 2012-2014
  • Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
  • Table 9-4: IBA - Strengths and Weaknesses
  • Table 9-5: Hitachi - Key Financials (Billion US$), 2012-2014
  • Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
  • Table 9-7: Hitachi - Strengths and Weaknesses
  • Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
  • Table 9-9: Mevion - Strengths and Weaknesses
  • Table 9-10: Varian - Proton Therapy Products and Services
  • Table 9-11: Varian - Key Financials (Billion US$), 2012-2014
  • Table 9-12: Varian: Proton Therapy Installations
  • Table 9-13: Varian - Strengths and Weaknesses
Back to Top